As AI accelerates target discovery and pushes more candidates toward the bench, assay development and transfer have become critical bottlenecks. Teams relying on one-factor-at-a-time (OFAT) workflows ...
FDA expansion allows clinician-collected primary HPV screening using Aptima, complementing established Pap-only and co-testing strategies within Hologic’s cervical screening portfolio. E6/E7 mRNA ...
A recently declassified document from nearly 50 years ago provides an important piece of the puzzle for open-source researchers seeking to understand the murky origins of the International Atomic ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Urea monitoring in biological fluids is of crucial significance, since urea is a key ...
This study evaluated the biological importance of immobilized urease enzyme over the free urease. The support material used for urease immobilization was alginate. Generally, the immobilization of ...
Please provide your email address to receive an email when new articles are posted on . A novel assay may help direct antibody-drug conjugate therapy through measurements of HER2 and TROP2. Most ...
A team of researchers has developed a new biosensor that turns the invisible signals into visible color changes to detect urea levels in a simple way. The sensor works by combining gold nanoparticles ...
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...
A bottleneck to enabling widespread access to molecular diagnostics, especially in low- and middle-income countries, has been the high cost and complex logistics associated with rapid point-of-care ...
Biomarker testing identifies high-risk early-stage NSCLC patients for adjuvant chemotherapy, reducing recurrence risk by 78%. The AIM-HIGH study shows a 96% disease-free survival rate at 24 months ...
In the years after the 2020 COVID-19 pandemic, it is clear that mRNA as a modality for vaccines and therapeutics is here to stay based on the number of mRNA programs currently in clinical development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results